CE25-028 - assessing the effectiveness of screening, brief intervention, and referral to treatment (sbirt) to reduce polysubstance impaired driving among emerging adults aged 18-30 in washington…

The Centers for Disease Control and Prevention awarded a $1,049,288 cooperative agreement to the University of Washington on September 30, 2025, to assess the effectiveness of screening, brief intervention, and referral to treatment (SBIRT) in reducing polysubstance impaired driving among emerging adults aged 18–30 in Washington State under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136).

The award funds the design, implementation, and evaluation of SBIRT interventions targeting the intersection of substance use and impaired driving risk in the 18–30 demographic. The program aims to generate evidence on intervention effectiveness through structured screening and brief clinical engagement followed by formal treatment referral pathways.

The University of Washington, through its Office of Sponsored Programs, is the recipient. Performance occurs in Washington State. The period of performance runs from September 30, 2025, through September 29, 2028. This is the initial budget period; subject to satisfactory progress and fund availability, the award supports continuation through the full project period under the cooperative agreement structure authorized under section 392(a)(1) of the Public Health Service Act.

CE25-028 - assessing the effectiveness of screening, brief intervention, and referral to treatment (sbirt) to reduce polysubstance impaired driving among emerging adults aged 18-30 in washington state.